Your browser doesn't support javascript.
loading
Genetic drivers and cellular selection of female mosaic X chromosome loss.
Liu, Aoxing; Genovese, Giulio; Zhao, Yajie; Pirinen, Matti; Zekavat, Seyedeh M; Kentistou, Katherine A; Yang, Zhiyu; Yu, Kai; Vlasschaert, Caitlyn; Liu, Xiaoxi; Brown, Derek W; Hudjashov, Georgi; Gorman, Bryan R; Dennis, Joe; Zhou, Weiyin; Momozawa, Yukihide; Pyarajan, Saiju; Tuzov, Valdislav; Pajuste, Fanny-Dhelia; Aavikko, Mervi; Sipilä, Timo P; Ghazal, Awaisa; Huang, Wen-Yi; Freedman, Neal D; Song, Lei; Gardner, Eugene J; Sankaran, Vijay G; Palotie, Aarno; Ollila, Hanna M; Tukiainen, Taru; Chanock, Stephen J; Mägi, Reedik; Natarajan, Pradeep; Daly, Mark J; Bick, Alexander; McCarroll, Steven A; Terao, Chikashi; Loh, Po-Ru; Ganna, Andrea; Perry, John R B; Machiela, Mitchell J.
Afiliación
  • Liu A; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland. liuaoxin@broadinstitute.org.
  • Genovese G; Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, MA, USA. liuaoxin@broadinstitute.org.
  • Zhao Y; Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA. liuaoxin@broadinstitute.org.
  • Pirinen M; Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA. liuaoxin@broadinstitute.org.
  • Zekavat SM; Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA. liuaoxin@broadinstitute.org.
  • Kentistou KA; Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA. giulio@broadinstitute.org.
  • Yang Z; Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA. giulio@broadinstitute.org.
  • Yu K; Department of Genetics, Harvard Medical School, Boston, MA, USA. giulio@broadinstitute.org.
  • Vlasschaert C; MRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge, Cambridge, UK.
  • Liu X; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland.
  • Brown DW; Department of Public Health, University of Helsinki, Helsinki, Finland.
  • Hudjashov G; Department of Mathematics and Statistics, University of Helsinki, Helsinki, Finland.
  • Gorman BR; Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Dennis J; Cardiovascular Research Center, Massachusetts General Hospital, Boston, MA, USA.
  • Zhou W; Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA.
  • Momozawa Y; MRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge, Cambridge, UK.
  • Pyarajan S; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland.
  • Tuzov V; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
  • Pajuste FD; Department of Medicine, Queen's University, Kingston, Ontario, Canada.
  • Aavikko M; Laboratory for Statistical and Translational Genetics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
  • Sipilä TP; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
  • Ghazal A; Cancer Prevention Fellowship Program, Division of Cancer Prevention, National Cancer Institute, Rockville, MD, USA.
  • Huang WY; Estonian Genome Centre, Institute of Genomics, University of Tartu, Tartu, Estonia.
  • Freedman ND; Center for Data and Computational Sciences (C-DACS), VA Cooperative Studies Program, VA Boston Healthcare System, Boston, MA, USA.
  • Song L; Booz Allen Hamilton, McLean, VA, USA.
  • Gardner EJ; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Sankaran VG; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Palotie A; Estonian Genome Centre, Institute of Genomics, University of Tartu, Tartu, Estonia.
  • Ollila HM; Estonian Genome Centre, Institute of Genomics, University of Tartu, Tartu, Estonia.
  • Tukiainen T; Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia.
  • Chanock SJ; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland.
  • Mägi R; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland.
  • Natarajan P; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland.
  • Daly MJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
  • Bick A; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
  • McCarroll SA; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
  • Terao C; MRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge, Cambridge, UK.
Nature ; 631(8019): 134-141, 2024 Jul.
Article en En | MEDLINE | ID: mdl-38867047
ABSTRACT
Mosaic loss of the X chromosome (mLOX) is the most common clonal somatic alteration in leukocytes of female individuals1,2, but little is known about its genetic determinants or phenotypic consequences. Here, to address this, we used data from 883,574 female participants across 8 biobanks; 12% of participants exhibited detectable mLOX in approximately 2% of leukocytes. Female participants with mLOX had an increased risk of myeloid and lymphoid leukaemias. Genetic analyses identified 56 common variants associated with mLOX, implicating genes with roles in chromosomal missegregation, cancer predisposition and autoimmune diseases. Exome-sequence analyses identified rare missense variants in FBXO10 that confer a twofold increased risk of mLOX. Only a small fraction of associations was shared with mosaic Y chromosome loss, suggesting that distinct biological processes drive formation and clonal expansion of sex chromosome missegregation. Allelic shift analyses identified X chromosome alleles that are preferentially retained in mLOX, demonstrating variation at many loci under cellular selection. A polygenic score including 44 allelic shift loci correctly inferred the retained X chromosomes in 80.7% of mLOX cases in the top decile. Our results support a model in which germline variants predispose female individuals to acquiring mLOX, with the allelic content of the X chromosome possibly shaping the magnitude of clonal expansion.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Células Clonales / Cromosomas Humanos X / Aneuploidia / Leucocitos / Mosaicismo Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Nature Año: 2024 Tipo del documento: Article País de afiliación: Finlandia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Células Clonales / Cromosomas Humanos X / Aneuploidia / Leucocitos / Mosaicismo Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Nature Año: 2024 Tipo del documento: Article País de afiliación: Finlandia